5-(3-hydroxyphenyl)-5-phenylhydantoin has been researched along with Chromosome-Defective Micronuclei in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, PM; Parman, T; Wells, PG; Winn, LM | 1 |
1 other study(ies) available for 5-(3-hydroxyphenyl)-5-phenylhydantoin and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Topics: Animals; Anticonvulsants; Cells, Cultured; Chromatography, High Pressure Liquid; DNA; Embryo, Mammalian; Female; Glucuronosyltransferase; Male; Mice; Micronuclei, Chromosome-Defective; Organ Culture Techniques; Oxidation-Reduction; Phenytoin; Rats; Rats, Gunn; Rats, Wistar | 1997 |